share_log

American International Holdings Corp. Appoints Chief Financial Officer

American International Holdings Corp. Appoints Chief Financial Officer

美國國際控股公司任命首席財務官
GlobeNewswire ·  2022/02/23 09:06

Plano, Texas, Feb. 23, 2022 (GLOBE NEWSWIRE) -- American International Holdings Corp. (OTCQB: AMIH), ("AMIH" or the "Company") a diversified holding company that develops, acquires and operates technology-based health and wellness companies, is pleased to announce its Board of Directors has appointed Dr. Craig Hewitt, as Chief Financial Officer (CFO) of the Company. Dr. Hewitt will begin his role as CFO effective the day following the upcoming filing of the Company's Annual Report on Form 10-K for the year ended December 31, 2021.

得克薩斯州普萊諾,2022年2月23日(環球通訊社)亞洲網加利福尼亞州聖何塞2月18日電美國國際控股公司(場外交易市場代碼:AMIH)(以下簡稱“AMIH”或“公司”)是一家多元化控股公司,致力於開發、收購和運營以技術為基礎的健康和保健公司。該公司高興地宣佈,其董事會已任命Craig Hewitt博士為公司首席財務官(CFO)。休伊特博士將在公司即將提交截至2021年12月31日的10-K表格年度報告的第二天開始擔任首席財務官。

Jacob Cohen, President and CEO of AMIH, commented, "I am thrilled to have someone with Craig's character, leadership, and experience joining our executive team. Over the last several months, we have made key additions to our leadership team, and the appointment of Craig to the CFO position reflects our commitment to recruit highly talented and experienced individuals who have a strong track record of success. Craig's extensive experience as a chief financial officer of healthcare related companies and his extensive background in strategic planning, corporate finance, compliance and regulatory matters, combined with his public company experience, make him an ideal choice to lead AMIH's financial compliance initiatives."

AMIH總裁兼首席執行官雅各布·科恩(Jacob Cohen)表示:“我很高興有一位像克雷格這樣性格、領導能力和經驗豐富的人加入我們的執行團隊。在過去的幾個月裏,我們對領導團隊進行了關鍵的補充,任命克雷格擔任首席財務官反映了我們致力於招聘有良好成功記錄的才華橫溢、經驗豐富的個人。克雷格作為醫療保健相關公司的首席財務官擁有豐富的經驗,他在戰略規劃、公司融資、合規和監管事務方面擁有廣泛的背景,再加上他在上市公司的經驗。

Dr. Hewitt has nearly 20 years of experience serving in executive management and leadership roles for companies in the health services and business services sectors. Dr. Hewitt most recently served as Chief Financial Officer of Holston Medical Group, an independent physician group of over 220 primary care physicians, specialists and mid-level providers with over 1,000 employees. Dr. Hewitt was a co-founder of, and Chief Executive Officer of, Legacy Financial Partners, a business services provider, between 2010 and 2015. From 2005 to 2009, Dr. Hewitt served as Chief Operating Officer and Interim Chief Executive Officer of Surrex Solutions, a high-tech staffing company with over 600 employees and branch offices in 23 states, while also serving as a member of Surrex's Board of Directors, Audit Committee, and Compensation Committee. Between 2002 and 2005, Dr. Hewitt served as Chief Financial Officer of Accupoll, Inc., a company engaged in the design, development, and sale of electronic voting systems and related technologies, where he was also a member of the Board of Directors, Audit Committee, and Compensation Committee. From 1999 to 2002, Dr. Hewitt served as Chief Financial Officer of Universal Broadband Networks and from 1995 to 1999, Dr. Hewitt served as Chief Financial Officer of Compreview, Inc.

休伊特博士擁有近20年在衞生服務和商業服務領域公司擔任行政管理和領導職務的經驗。休伊特博士最近擔任霍爾斯頓醫療集團(Holston Medical Group)的首席財務官。霍爾斯頓醫療集團是一個獨立的醫生集團,由220多名初級保健醫生、專家和中級提供者組成,擁有1000多名員工。休伊特博士在2010年至2015年期間是商業服務提供商Legacy Financial Partners的聯合創始人兼首席執行官。2005年至2009年,休伊特博士擔任Surrex Solutions的首席運營官和臨時首席執行官,該公司是一家高科技人力資源公司,在23個州擁有600多名員工和分支機構,同時還擔任Surrex董事會、審計委員會和薪酬委員會的成員。2002年至2005年間,休伊特博士曾擔任Accupoll公司的首席財務官,該公司從事電子投票系統和相關技術的設計、開發和銷售,他也是該公司董事會、審計委員會和薪酬委員會的成員。1999年至2002年,休伊特博士擔任環球寬帶網絡公司的首席財務官,1995年至1999年,休伊特博士擔任康普萊斯公司的首席財務官。

In 2021, Dr. Hewitt received his Ph.D in Health Science from Trident University, in Cypress California, where he also earned a Master's degree in Healthcare in 2017. Dr. Hewitt received a Master's degree in Business Administration from Western Governors University in Salt Lake City, Utah, in 2015 and a Bachelor's degree in Business Administration from California State University, Fullerton, in 1990.

2021年,休伊特博士在加利福尼亞州賽普拉斯的三叉戟大學獲得了健康科學博士學位,並於2017年在那裏獲得了醫療保健碩士學位。休伊特博士於2015年獲得猶他州鹽湖城西部州長大學工商管理碩士學位,1990年獲得加州州立大學富勒頓分校工商管理學士學位。

Dr. Hewitt commented, "I am very excited to be joining the management team of AMIH. I look forward to adding my expertise to the talented group of team members throughout the organization and working with AMIH as it seeks to grow in the years ahead."

休伊特博士評論説:“能夠加入AMIH的管理團隊,我感到非常興奮。我期待着將我的專業知識加入到整個組織的團隊成員中,並與AMIH合作,使其在未來幾年不斷髮展。”

More information regarding Dr. Hewitt's appointment can be found in the Current Report on Form 8-K which the Company filed with the Securities and Exchange Commission on February 17, 2022.

有關休伊特博士任命的更多信息可在該公司於2022年2月17日提交給證券交易委員會的8-K表格的當前報告中找到。

About American International Holdings Corp.
American International Holdings Corp. (OTCQB: AMIH) is an investor, developer and asset manager of diversified, synergistic health and wellness businesses. Today, the AMIH portfolio encompasses telemedicine and other virtual health platforms, affordable subscriber-based primary care and concierge medicine plans, preventative care solutions and wellness related assets such as mental & behavioral health services, as well as its own proprietary life coaching platform. AMIH markets its various services through direct-to-consumer and business-to-business distribution channels. AMIH's focus is on bringing to market technologies and solutions that advance the quality of life for the global community.

關於美國國際米蘭國家控股公司(National Holdings Corp.)
美國國際控股公司(場外交易市場代碼:AMIH)是多元化協同健康業務的投資者、開發商和資產管理公司。今天,AMIH的產品組合包括遠程醫療和其他虛擬健康平臺、負擔得起的基於訂户的初級保健和禮賓醫療計劃、預防性保健解決方案和與健康相關的資產(如心理和行為健康服務),以及自己的專有生活指導平臺。AMIH通過直接對消費者和企業對企業分銷渠道營銷其各種服務。AMIH的重點是將提高全球社會生活質量的技術和解決方案推向市場。

Forward-Looking Statements
This press release may contain forward-looking statements, including information about management's view of the Company's future expectations, plans and prospects, within the meaning of the federal securities laws, including the Private Securities Litigation Reform Act of 1995. Forward-looking statements also may be included in other publicly available documents issued by the Company and in oral statements made by our officers and representatives from time to time. These forward-looking statements are intended to provide management's current expectations or plans for our future operating and financial performance, based on assumptions currently believed to be valid. They can be identified by the use of words such as "anticipate," "intend," "plan," "goal," "seek," "believe," "project," "estimate," "expect," "strategy," "future," "likely," "may," "should," "would," "could," "will" and other words of similar meaning in connection with a discussion of future operating or financial performance. Examples of forward-looking statements include, among others, statements relating to future sales, operations, expansion, earnings, cash flows, results of operations, uses of cash and other measures of financial performance. Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and other factors that may cause the Company's actual results and financial condition to differ materially from those expressed or implied in the forward-looking statements. Such risks, uncertainties and other factors include, among others such as, but not limited to the proposed operations of the Company's subsidiary, EPIQ Scripts, the ability of EPIQ Scripts to obtain required licenses and accreditations, the timing of such licenses and accreditations, and limitations on its operations if such licenses and accreditations are not in place, and future projected revenues, customers, and results of operations of EPIQ Scripts; economic conditions, changes in the laws or regulations, demand for products and services of the Company; our limited operating history; our need for additional funding to support our operations, repay debt and expand our operations; the effects of COVID-19 on our operations and prospects, and the future effects of COVID-19 on us and our operations; impairments we may be required to assess in connection with our assets and goodwill; risks associated with our prior launch of a telehealth platform, including liability in connection therewith, funding needed to support such operations and other risks associated with the operations of the telehealth platform; disruptions to our operations or liabilities associated with future acquisitions; our ability to continue as a going concern; our dependence on our Chief Executive Officer, Jacob D. Cohen, and related party transactions affecting the Company; Mr. Cohen's voting control over the Company; competition we face; our ability to maintain our varied operations, and service our indebtedness; material weaknesses in our controls and procedures; our ability to obtain and maintain adequate insurance; legal challenges and litigation; liability associated with our contracting operations; the terms of Mr. Cohen's employment agreement; dilution caused by the conversion of outstanding notes, exercise of outstanding warrants, and future fund-raising activities; anti-dilution and favored nation provisions of our outstanding convertible notes and warrants; the price of, volatility in, and lack of robust trading market for, our common stock; meeting the listing standards and the Company's ability to uplist on NASDAQ; and other factors that could cause actual results to differ materially from those projected or represented in the forward-looking statements. These risk factors and others are included from time to time in filings made by the Company with the Securities and Exchange Commission, including, but not limited to, in the "Risk Factors" sections in its Form 10-Ks and Form 10-Qs and in its Form 8-Ks, which it has filed, and files from time to time, with the U.S. Securities and Exchange Commission. These reports are available at www.sec.gov. The forward-looking statements included in this press release are made only as of the date hereof. The Company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. We undertake no obligation to update publicly any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable laws. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements.

前瞻性陳述
本新聞稿可能包含前瞻性陳述,包括有關管理層對公司未來預期、計劃和前景的看法的信息,符合聯邦證券法的含義,包括1995年的“私人證券訴訟改革法案”。前瞻性陳述也可能包含在公司發佈的其他公開文件中,以及我們的官員和代表不時發表的口頭聲明中。這些前瞻性陳述旨在根據目前被認為有效的假設,提供管理層對我們未來經營和財務業績的當前預期或計劃。它們可以通過使用諸如“預期”、“打算”、“計劃”、“目標”、“尋求”、“相信”、“項目”、“估計”、“預期”、“戰略”、“未來”、“可能”、“應該”、“將會”、“可能”、“將”等與討論未來經營或財務業績相關的類似含義的詞語來識別。前瞻性陳述的例子包括與未來銷售、運營、擴張、收益、現金流、經營結果、現金使用以及其他財務業績衡量標準有關的陳述。由於前瞻性陳述與未來有關,它們會受到固有風險、不確定因素和其他因素的影響,這些風險、不確定因素和其他因素可能會導致公司的實際結果和財務狀況與前瞻性陳述中明示或暗示的大不相同。這些風險、不確定因素和其他因素包括但不限於公司子公司EPIQ Scripts的擬議運營、EPIQ Scripts獲得所需許可證和認證的能力、此類許可證和認證的時間、以及在此類許可證和認證未到位時對其運營的限制,以及未來預計的收入、客户, 這些因素包括:公司業績和經營業績;經濟狀況、法律法規的變化、對公司產品和服務的需求;公司有限的經營歷史;需要額外資金來支持我們的經營、償還債務和擴大經營;新冠肺炎對我們經營和前景的影響,以及新冠肺炎對我們和我們經營的未來影響;我們可能需要評估與我們的資產和商譽相關的減損;與我們以前推出遠程醫療平臺相關的風險,包括與之相關的責任、支持此類業務和其他所需資金。我們的經營中斷或與未來收購相關的負債;我們繼續經營下去的能力;我們對首席執行官雅各布·D·科恩的依賴,以及影響公司的關聯方交易;科恩先生對公司的表決權控制;我們面臨的競爭;我們維持我們多樣化業務和償還債務的能力;我們在控制和程序方面的重大弱點;我們獲得和維持足夠保險的能力;法律挑戰和訴訟;與我們承包業務相關的責任;科恩先生的僱傭協議的條款;因轉換未償還票據、行使未償還認股權證及未來集資活動而導致的攤薄;我們的未償還可轉換票據及認股權證的反攤薄及優惠國條款;以下各項的價格、波動性及缺乏強勁的交易市場, 這些因素可能會導致實際結果與前瞻性表述中的預測或表述大相徑庭,包括:公司股票和我們的普通股狀況;符合上市標準和公司在納斯達克上市的能力;以及其他可能導致實際結果與前瞻性表述中預測或表述的結果大不相同的因素。這些風險因素和其他風險因素包括在該公司不時向美國證券交易委員會提交的文件中,包括但不限於其提交給美國證券交易委員會的Form 10-K和Form 10-Q以及Form 8-K中的“風險因素”部分。這些報告可在www.sec.gov上查閲。本新聞稿中包含的前瞻性陳述僅在本新聞稿發佈之日作出。公司不能保證未來的結果、活動水平、業績或成就。因此,您不應過度依賴這些前瞻性陳述。我們沒有義務公開更新這些前瞻性表述中的任何一項,以反映實際結果、新信息或未來事件、假設的變化或其他影響前瞻性表述的因素的變化,除非適用法律要求。如果我們更新一個或多個前瞻性陳述,不應推斷我們將對這些或其他前瞻性陳述進行額外更新。

Investor Relations Contact
Dave Gentry, CEO
RedChip Companies Inc.
407-491-4498
AMIH@redchip.com

投資者關係聯繫人
首席執行官戴夫·金特里(Dave Gentry)
紅籌公司(RedChip Companies Inc.)
407-491-4498
郵箱:amIH@redchip.com

Frank Benedetto
(619) 915-9422

弗蘭克·貝尼代託
(619) 915-9422


声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論